Ketohexokinase inhibitor 1

CAS No. 2102501-84-6

Ketohexokinase inhibitor 1( —— )

Catalog No. M23954 CAS No. 2102501-84-6

Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 500 In Stock
10MG 713 In Stock
25MG 1062 In Stock
50MG 1431 In Stock
100MG 1935 In Stock
500MG 3888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ketohexokinase inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.
  • Description
    Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor (IC50s: 8.4 nM and 66 nM for KHK-C and KHK-A, respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    KHK-A|KHK-C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2102501-84-6
  • Formula Weight
    356.34
  • Molecular Formula
    C16H19F3N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (350.79 mM)
  • SMILES
    C[C@@H](CC1)N1c1nc(N(C2)C[C@@H]3[C@H]2C3CC(O)=O)cc(C(F)(F)F)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS. US 20170183328 A1
molnova catalog
related products
  • Hexa-His

    Hexa His is an amino acid sequence consisting of 6 His residues in a row, it is also known as hexa histidine-tag, 6xHis-tag, and by the trademarked name His-tag. Hexa His Responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues.

  • TG2-IN-3h

    TG2-IN-3h is a transglutaminase (TGase) inhibitor used in the study of neurological and immune system disorders.

  • KRM-III

    KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM.